NovaBay Pharmaceuticals Statistics
Total Valuation
NBY has a market cap or net worth of $3.47 million. The enterprise value is $3.96 million.
Important Dates
The last earnings date was Thursday, November 7, 2024, after market close.
| Earnings Date | Nov 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
NBY has 4.89 million shares outstanding. The number of shares has increased by 1,605.55% in one year.
| Current Share Class | 4.89M |
| Shares Outstanding | 4.89M |
| Shares Change (YoY) | +1,605.55% |
| Shares Change (QoQ) | +221.21% |
| Owned by Insiders (%) | 0.01% |
| Owned by Institutions (%) | 2.18% |
| Float | 4.88M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.07 |
| Forward PS | 0.17 |
| PB Ratio | 3.25 |
| P/TBV Ratio | 3.25 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.29 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.15, with a Debt / Equity ratio of 1.18.
| Current Ratio | 1.15 |
| Quick Ratio | 0.75 |
| Debt / Equity | 1.18 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -273.79% and return on invested capital (ROIC) is -56.53%.
| Return on Equity (ROE) | -273.79% |
| Return on Assets (ROA) | -41.80% |
| Return on Capital (ROIC) | -56.53% |
| Revenue Per Employee | $532,462 |
| Profits Per Employee | -$637,115 |
| Employee Count | 26 |
| Asset Turnover | 1.66 |
| Inventory Turnover | 2.92 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -93.90% in the last 52 weeks. The beta is 0.73, so NBY's price volatility has been lower than the market average.
| Beta (5Y) | 0.73 |
| 52-Week Price Change | -93.90% |
| 50-Day Moving Average | 0.66 |
| 200-Day Moving Average | 2.35 |
| Relative Strength Index (RSI) | 53.00 |
| Average Volume (20 Days) | 1,144,371 |
Short Selling Information
The latest short interest is 764,279, so 15.64% of the outstanding shares have been sold short.
| Short Interest | 764,279 |
| Short Previous Month | 451,713 |
| Short % of Shares Out | 15.64% |
| Short % of Float | 15.66% |
| Short Ratio (days to cover) | 0.83 |
Income Statement
In the last 12 months, NBY had revenue of $13.84 million and -$16.57 million in losses. Loss per share was -$11.45.
| Revenue | 13.84M |
| Gross Profit | 7.87M |
| Operating Income | -5.59M |
| Pretax Income | -11.12M |
| Net Income | -16.57M |
| EBITDA | -5.40M |
| EBIT | -5.59M |
| Loss Per Share | -$11.45 |
Full Income StatementBalance Sheet
The company has $776,000 in cash and $1.26 million in debt, giving a net cash position of -$486,000 or -$0.10 per share.
| Cash & Cash Equivalents | 776,000 |
| Total Debt | 1.26M |
| Net Cash | -486,000 |
| Net Cash Per Share | -$0.10 |
| Equity (Book Value) | 1.07M |
| Book Value Per Share | 0.22 |
| Working Capital | 295,000 |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$4.73 million and capital expenditures -$9,000, giving a free cash flow of -$4.74 million.
| Operating Cash Flow | -4.73M |
| Capital Expenditures | -9,000 |
| Free Cash Flow | -4.74M |
| FCF Per Share | -$0.97 |
Full Cash Flow StatementMargins
Gross margin is 56.87%, with operating and profit margins of -40.41% and -73.09%.
| Gross Margin | 56.87% |
| Operating Margin | -40.41% |
| Pretax Margin | -80.19% |
| Profit Margin | -73.09% |
| EBITDA Margin | -38.99% |
| EBIT Margin | -40.41% |
| FCF Margin | -28.81% |
Dividends & Yields
NBY does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1,605.55% |
| Shareholder Yield | -1,605.55% |
| Earnings Yield | -478.21% |
| FCF Yield | -136.81% |
Analyst Forecast
The average price target for NBY is $0.85, which is 19.72% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $0.85 |
| Price Target Difference | 19.72% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on May 31, 2024. It was a reverse split with a ratio of 0.028571429:1.
| Last Split Date | May 31, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.028571429:1 |
Scores
NBY has an Altman Z-Score of -66.43 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -66.43 |
| Piotroski F-Score | 3 |